Stevanato Group
Glass & Clay · Italy · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
Via Molinella 17, Piombino Dese, Veneto,...Phone Number
+39 49931811Website
www.stevanatogroup.comRevenue
$1.3 BillionStock Symbol
STVNIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Stevanato Group
Stevanato Group is one of the world's largest providers of integrated containment and delivery solutions for the biopharmaceutical industry.From the beginning, the Group has developed its own glass forming technology to ensure quality of the highest standards. The Group includes a wide range of skills dedicated to serving the biopharmaceutical and diagnostic industry. It offers glass containers with its historic Ompi brand, plastic components for diagnostics and medical devices, contract manufacturing services for drug delivery systems, up to inspection, assembly and packaging machines.Explore more
Stevanato Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stevanato Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Stevanato Group recently announced quarterly report
Check if Stevanato Group has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Stevanato Group has new funding data
Product Launch: Get notified when Stevanato Group launches new products
Click to see if Stevanato Group had a recent Job posting/layoffs
Stevanato Group, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Stevanato Group
Website visits: Recent activity has been detected on your website
Check out if Stevanato Group is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Stevanato Group
Find 2 more new buyers
Company Profile Activity
Activity Insights
Stevanato Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stevanato Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stevanato Group.
Stevanato Group financials insights
Gather financial insights about Stevanato Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Share Placement
$672M
2023
Debt
$137M
2025
Debt
$235.4M
Stevanato Group Tech Stack
A closer look at the technologies used by Stevanato Group
See more technologies
Most Recent Scoops
Earnings
Stevanato Group has updated its full-year fiscal 2026 revenue guidance to a range of EUR 1.160 billion to EUR 1.280 billion, incorporating an approximately EUR 15 million revenue reduction from the divestiture of Balda C. Brewer, partially offset by favorable currency translation and higher organic growth; adjusted EBITDA is now expected between EUR 335 million and EUR 345.2 million, and adjusted diluted EPS is expected to range between $0.60 and $0.62.
Earnings, Divestitures, Finance
Event
Product Marketing, Events, Automation, Sales, Software, Logistics / Supply Chain, Machinery, Field /Outside Sales, Field Marketing, Manufacturing Operations, Operations, Warehouse Operations
Earnings
reported BDS segment revenue of EUR 266.2 million for Q2 2026, an increase of 9% on a reported basis and 10% at constant currency, with High-Value Solutions revenue rising 16% to EUR 135.9 million and representing approximately 51% of segment revenue, driven by strong growth in premium Nexa syringes, Alba syringes, and EZ-fill vials.
Earnings, Finance
Earnings
provided full-year 2026 guidance assumptions including high single-digit reported growth for the BDS segment, a mid-single-digit to low double-digit decline for the Engineering segment, High-Value Solutions representing 47% to 48% of total company revenue, free cash flow ranging from breakeven to EUR +20 million, and an updated tax rate of approximately 28.2%.
Earnings, Accounting, Forecasting, Financial Reporting, Business Finance, Finance, Tax
Earnings
Earnings, Finance, Financial Operations, Manufacturing Operations
Stevanato Group News & Media
Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Stevanato Group S.p.A. (STVN) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 1:50 PM EDTCompany ParticipantsMarco Dal Lago -...Stevanato Group (STVN) Trades A Subsidiary For Margin Gains And Growth
On August 4, Stevanato Group (NYSE:STVN) reported second-quarter revenue of €302.0 million, up 8% year over year, while also closing the sale of its California-based subsidiary, Balda C. Brewer Inc. The results paired steady growth in the company’s core drug containment and delivery business with a portfolio move that reshaped its bottom line for the […]Stevanato Group S.p.A. (STVN) Q2 2026 Earnings Call Transcript
Stevanato Group S.p.A. (STVN) Q2 2026 Earnings Call August 4, 2026 8:30 AM EDTCompany ParticipantsLisa Miles - Chief Communications & Investor Relations...
Read more news
Top Glass & Clay Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stevanato Group
Sign Up For FreeTo access detailed company insights
Stevanato Group is one of the world's largest providers of integrated containment and delivery solutions for the biopharmaceutical industry.From the beginning, the Group has developed its own glass forming technology to ensure quality of the highest standards. The Group includes a wide range of skills dedicated to serving the biopharmaceutical and... Read More
